Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
| Website | https://www.pathalys.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2021 |
| Address | 4242 Six Forks Road Suite 820, Raleigh, North Carolina 27609, US |
| Industry | Biotechnology Research |
| Keywords | Chronic Kidney Disease, Biopharmaceutical, Ckd Treatment, Renal Disease, Clinical Stage, Drug Development, Advanced Therapeutics, Clinical Trials, Therapeutics, Unmet Medical Needs, Drug Discovery, Pharmaceutical Research, Disease Treatment, Biotechnology, Patient Care, Pharmaceutical, Health Care, Medicine |
| Competitors | Roche, Merck AH, AbbVie, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Pfizer, Lilly India +40 more (view full list) |
Looking for a particular Pathalys Pharma employee's phone or email?
Neal Fowler is the CEO of Pathalys Pharma.
10 people are employed at Pathalys Pharma.
Pathalys Pharma is based in Raleigh, North Carolina.